Guangxi Xianzhu Pharmaceutical Co., Ltd. announced that it will raise CNY 50 million in an equity funding on May 31, 2024. The transaction will include participation from new investor,Guangxi LiuYao Group Co., Ltd. The transaction has been approved at the 16th meeting of the 5th Board of Directors and the 13th meeting of the 5th Board of Supervisors. Upon the closing, the company's registered capital will increased from CNY 50 million to CNY 100 million.